By visiting our website or using services provided by Sai Life Sciences, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking “I Accept”, you confirm that you are above the age of 16, that you have read and understood the Cookies Usage and the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Sai Life in accordance with said policies.
In a review article published in the latest edition of Materials Today Bio, titled ‘Liver-on-Chips for Drug Discovery and Development,’ our scientists, Dr. Viraj Mehta, Dr. Guruswamy Karnam, and Dr. Vamsi Madgula from DMPK, have highlighted the transformative impact of advanced in vitro 3D models on pharmaceutical research and development (R&D). The review article delves […] Read more
From Commitment to Action: Sai Life Sciences makes strides towards a greener earth
On the World Environment Day, we reflect on the efforts we’ve taken towards sustainability. A year ago, on June 5th, 2023, Sai Life Sciences renewed its Sustainable Development Goals (SDGs), charting a roadmap to achieve specific environmental, social, and governance (ESG) targets by FY27, with FY22 as the baseline year. Three of these SDGs pertain […]
In the 1936 Charlie Chaplin movie “Modern Times”, we see several hilarious attempts by the Management of Electro Steel Corp at raising the productivity of their factory workers, ranging from speeding up their assembly line to deploying a robotic feeding machine to keep them working even during lunch. While the movie is exaggerated to prove […]
Computational insights into mixing: How process engineers are leveraging simulation in multiphase systems
Mixing in a multiphase system, especially in a scale-up environment, can prove to be an uphill task. A thorough understanding of mixing patterns is crucial as it enables the optimization of process parameters, reactor design, and operational conditions. It also aids in controlling phase separations and preventing undesirable side reactions. Process engineers are leveraging simulation […]
A Stitch in Time Saves Nine: Decoding Pharmaceutical Developability Assessment of NCEs
The developability assessment of new chemical entities (NCEs) is a crucial step in the drug discovery and development cycle. It involves an evaluation of a potential lead candidate’s/compound’s chances of becoming a clinical drug candidate at an early phase. The goal is to characterize the clinical drug candidate, identify, and address any potential challenges that […]
Embracing electrophysiology to revolutionize drug discovery: utility beyond safety pharmacology
When MS Dhoni in his inimitable style flicks one over the ropes, our hearts collectively skip a beat. The answer of this phenomenon, that is being experienced by millions of cricket enthusiast this IPL season, lies in electrophysiology, the study of electrical properties of cells and tissues. In drug discovery process, electrophysiology has the potential […]
Innovative use of Spherical Agglomeration at scale to manufacture API with improved ‘flow’ property
Solving tough scientific challenges is our raison d’etre. This often leads us along under-explored paths that are both challenging and exciting. One of the sophisticated particle design techniques that is used to improve an API particle’s ‘flow property’, among other physical properties, is Spherical Agglomeration. This technique is considered to be a complex one – […]
How PAT tools can help improve understanding of the crystallisation process
The criticality of Crystallisation process in the manufacture of drug substancesThe importance of crystallisation in the pharmaceutical and high-value chemical industries has increased recently due to many technical and commercial factors in last decade: These demands denote the process development is now more focused than ever before, in developing better crystallisation processes for intermediates (where […]
Outsourcing of R&D and Manufacturing has seen over a 50% budget increase in 2021, according to a report by CPhI, the record number of investments in discovery pipelines coupled with broader macro factors is going to drive huge growth for CDMOs in the next 2-3 years. Full-service CDMOs, both large and medium scale, are looking […]
What is High Throughput Screening? The virtue of HTS If a methodology has to be nominated to the Science Hall of Fame for its contributions in the field of Biology and Chemistry and its interfaces, this is with no doubt High Throughput Screening (HTS). The concept is simple: testing large libraries of entities -compounds, biologicals […]
{
"@context": "https://schema.org",
"@type": "BlogPosting",
"headline": "Trends in High Throughput Screening",
"url": "https://www.sailife.com/trends-in-high-throughput-screening/",
"description": "An in-depth exploration of the latest advancements and methodologies in high throughput screening (HTS) within pharmaceutical research.",
"datePublished": "2024-02-18",
"dateModified": "2024-02-18",
"author": {
"@type": "Person",
"name": "Sai Life Sciences Research Team",
"affiliation": {
"@type": "Organization",
"name": "Sai Life Sciences"
}
},
"publisher": {
"@type": "Organization",
"name": "Sai Life Sciences",
"url": "https://www.sailife.com/",
"logo": {
"@type": "ImageObject",
"url": "https://www.sailife.com/wp-content/themes/sailife/images/logo.png"
}
},
"mainEntityOfPage": {
"@type": "WebPage",
"@id": "https://www.sailife.com/trends-in-high-throughput-screening/"
},
"articleBody": "High Throughput Screening (HTS) has become a cornerstone in drug discovery, enabling the rapid evaluation of large chemical libraries against biological targets. Recent trends in HTS focus on enhancing efficiency, accuracy, and data integration. Automation and miniaturization have significantly increased throughput, allowing for the screening of millions of compounds with reduced reagent consumption. The adoption of microfluidic systems and droplet-based technologies has further miniaturized assays, leading to cost-effective and scalable screening processes. Additionally, the integration of artificial intelligence and machine learning algorithms has improved hit identification and predictive modeling, streamlining the drug discovery pipeline. Advanced readout technologies, such as high-content imaging and label-free detection methods, provide comprehensive data on compound effects, facilitating better decision-making in lead selection. Collaborative platforms and open-source databases are also emerging, promoting data sharing and accelerating innovation in HTS methodologies.",
"keywords": ["High Throughput Screening", "Drug Discovery", "Automation", "Microfluidics", "Artificial Intelligence", "Machine Learning", "High-Content Imaging", "Label-Free Detection"],
"image": {
"@type": "ImageObject",
"url": "https://www.sailife.com/wp-content/uploads/high-throughput-screening.jpg",
"width": 1200,
"height": 630
}
}